Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Am J Respir Cell Mol Biol
2014 May 01;505:953-62. doi: 10.1165/rcmb.2013-0215OC.
Show Gene links
Show Anatomy links
Inter-α-inhibitor blocks epithelial sodium channel activation and decreases nasal potential differences in ΔF508 mice.
Lazrak A
,
Jurkuvenaite A
,
Ness EC
,
Zhang S
,
Woodworth BA
,
Muhlebach MS
,
Stober VP
,
Lim YP
,
Garantziotis S
,
Matalon S
.
???displayArticle.abstract???
Increased activity of lung epithelial sodium channels (ENaCs) contributes to the pathophysiology of cystic fibrosis (CF) by increasing the rate of epithelial lining fluid reabsorption. Inter-α-inhibitor (IαI), a serum protease inhibitor, may decrease ENaC activity by preventing its cleavage by serine proteases. High concentrations of IαI were detected in the bronchoalveolar lavage fluid (BALF) of children with CF and lower airway diseases. IαI decreased amiloride-sensitive (IENaC) but not cAMP-activated Cl(-) currents across confluent monolayers of rat ATII, and mouse nasal epithelial cells grew in primary culture by 45 and 25%, respectively. Changes in IENaC by IαI in ATII cells were accompanied by increased levels of uncleaved (immature) surface α-ENaC. IαI increased airway surface liquid depth overlying murine nasal epithelial cells to the same extent as amiloride, consistent with ENaC inhibition. Incubation of lung slices from C57BL/6, those lacking phenylalanine at position 508 (∆F508), or CF transmembrane conductance regulator knockout mice with IαI for 3 hours decreased the open probability of their ENaC channels by 50%. ∆F508 mice had considerably higher levels the amiloride-sensitive fractions of ENaC nasal potential difference (ENaC-NPD) than wild-type littermates and only background levels of IαI in their BALF. A single intranasal instillation of IαI decreased their ENaC-NPD 24 hours later by 25%. In conclusion, we show that IαI is present in the BALF of children with CF, is an effective inhibitor of ENaC proteolysis, and decreases ENaC activity in lung epithelial cells of ∆F508 mice.
Adair,
Inter-alpha-trypsin inhibitor promotes bronchial epithelial repair after injury through vitronectin binding.
2009, Pubmed
Adair,
Inter-alpha-trypsin inhibitor promotes bronchial epithelial repair after injury through vitronectin binding.
2009,
Pubmed
Balint,
Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis.
2001,
Pubmed
Bengrine,
Indirect activation of the epithelial Na+ channel by trypsin.
2007,
Pubmed
,
Xenbase
Bost,
Inter-alpha-trypsin inhibitor proteoglycan family--a group of proteins binding and stabilizing the extracellular matrix.
1998,
Pubmed
Boucher,
Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation.
1986,
Pubmed
Canessa,
Epithelial sodium channel related to proteins involved in neurodegeneration.
1993,
Pubmed
,
Xenbase
Carrell,
Alpha1-antitrypsin deficiency--a model for conformational diseases.
2002,
Pubmed
Chen,
DETANO and nitrated lipids increase chloride secretion across lung airway cells.
2008,
Pubmed
Chen,
Inhibition of Na+ transport in lung epithelial cells by respiratory syncytial virus infection.
2009,
Pubmed
Choi-Miura,
Proteolytic activation and inactivation of the serine protease activity of plasma hyaluronan binding protein.
2001,
Pubmed
Choi-Miura,
Hepatic injury-specific conversion of mouse plasma hyaluronan binding protein to the active hetero-dimer form.
2001,
Pubmed
Collawn,
The CFTR and ENaC debate: how important is ENaC in CF lung disease?
2012,
Pubmed
Collawn,
The role of CFTR in transepithelial liquid transport in pig alveolar epithelia.
2012,
Pubmed
Factor,
Adenosine regulation of alveolar fluid clearance.
2007,
Pubmed
Fan,
Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin.
2005,
Pubmed
Forteza,
Hyaluronan serves a novel role in airway mucosal host defense.
2001,
Pubmed
Fries,
Inter-alpha-inhibitor, hyaluronan and inflammation.
2003,
Pubmed
Garantziotis,
Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury.
2008,
Pubmed
Garantziotis,
Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice.
2009,
Pubmed
Griese,
alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients.
2007,
Pubmed
Haddad,
Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury.
1994,
Pubmed
Hughey,
Epithelial sodium channels are activated by furin-dependent proteolysis.
2004,
Pubmed
,
Xenbase
Hughey,
Maturation of the epithelial Na+ channel involves proteolytic processing of the alpha- and gamma-subunits.
2003,
Pubmed
,
Xenbase
Itani,
Human cystic fibrosis airway epithelia have reduced Cl- conductance but not increased Na+ conductance.
2011,
Pubmed
Janciauskiene,
Alpha1-antitrypsin inhibits the activity of the matriptase catalytic domain in vitro.
2008,
Pubmed
Ji,
Delta-subunit confers novel biophysical features to alpha beta gamma-human epithelial sodium channel (ENaC) via a physical interaction.
2006,
Pubmed
Knowles,
In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
1995,
Pubmed
Knowles,
Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.
1981,
Pubmed
Knowles,
Abnormal ion permeation through cystic fibrosis respiratory epithelium.
1983,
Pubmed
Kobayashi,
Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis.
1994,
Pubmed
Koo,
Cell-surface processing of pro-ADAMTS9 by furin.
2006,
Pubmed
König,
The cystic fibrosis transmembrane conductance regulator (CFTR) inhibits ENaC through an increase in the intracellular Cl- concentration.
2001,
Pubmed
,
Xenbase
Lazrak,
Enhancement of alveolar epithelial sodium channel activity with decreased cystic fibrosis transmembrane conductance regulator expression in mouse lung.
2011,
Pubmed
,
Xenbase
Lazrak,
Alpha(1)-antitrypsin inhibits epithelial Na+ transport in vitro and in vivo.
2009,
Pubmed
,
Xenbase
Lazrak,
Regulation of alveolar epithelial Na+ channels by ERK1/2 in chlorine-breathing mice.
2012,
Pubmed
Li,
CFTR is required for maximal transepithelial liquid transport in pig alveolar epithelia.
2012,
Pubmed
Lim,
Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis.
2003,
Pubmed
Malik,
Enac degradation in A6 cells by the ubiquitin-proteosome proteolytic pathway.
2001,
Pubmed
,
Xenbase
Malki,
The heavy chains of human plasma inter-alpha-trypsin inhibitor: their isolation, their identification by electrophoresis and partial sequencing. Differential reactivity with concanavalin A.
1992,
Pubmed
Mall,
Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.
2004,
Pubmed
Matalon,
Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance.
1999,
Pubmed
Myerburg,
Prostasin expression is regulated by airway surface liquid volume and is increased in cystic fibrosis.
2008,
Pubmed
Netzel-Arnett,
Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation.
2006,
Pubmed
Opal,
Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication.
2005,
Pubmed
Planès,
Hypoxia and beta 2-agonists regulate cell surface expression of the epithelial sodium channel in native alveolar epithelial cells.
2002,
Pubmed
Planès,
In vitro and in vivo regulation of transepithelial lung alveolar sodium transport by serine proteases.
2005,
Pubmed
Potempa,
The serpin superfamily of proteinase inhibitors: structure, function, and regulation.
1994,
Pubmed
Quinn,
Antiproteases as therapeutics to target inflammation in cystic fibrosis.
2010,
Pubmed
Rossier,
Epithelial sodium channels.
1994,
Pubmed
Rossier,
The epithelial sodium channel: activation by membrane-bound serine proteases.
2004,
Pubmed
Salinas,
CFTR involvement in nasal potential differences in mice and pigs studied using a thiazolidinone CFTR inhibitor.
2004,
Pubmed
Snouwaert,
An animal model for cystic fibrosis made by gene targeting.
1992,
Pubmed
Snyder,
Minireview: regulation of epithelial Na+ channel trafficking.
2005,
Pubmed
Staub,
Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination.
1997,
Pubmed
,
Xenbase
Taggart,
Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity.
2000,
Pubmed
Tucker,
CD40 ligation decreases its protein half-life at the cell surface.
2008,
Pubmed
Valentijn,
Biosynthesis and processing of epithelial sodium channels in Xenopus oocytes.
1998,
Pubmed
,
Xenbase
Vogel,
[Current aspects of kinin research. I. Potentiation and blocking of biological kinin activity].
1970,
Pubmed
Vuagniaux,
Activation of the amiloride-sensitive epithelial sodium channel by the serine protease mCAP1 expressed in a mouse cortical collecting duct cell line.
2000,
Pubmed
,
Xenbase
Woodworth,
Murine tracheal and nasal septal epithelium for air-liquid interface cultures: a comparative study.
2007,
Pubmed
Zeiher,
A mouse model for the delta F508 allele of cystic fibrosis.
1995,
Pubmed
Zhuo,
Structure and function of inter-alpha-trypsin inhibitor heavy chains.
2008,
Pubmed
